IL6 and breast carcinoma: Here, IL6 and HOXA4 were found to be specifically downregulated, and their low expression predicted low RFS in LumB-subtype breast cancer (p < 0.05), and the prognostic analysis result of IL6 was consistent with tha in all breast cancer.